Search Drug Adverse Events

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, destructiveHint=false, idempotentHint=true, openWorldHint=true. The description adds value by specifying the external database (FAERS via OpenFDA) and the nature of the data (adverse event reports), which helps the agent understand the scope and reliability. It does not contradict annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, well-structured sentence that front-loads the main action and key details. Every word adds value, and it is efficient without being verbose.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the existence of an output schema, the description does not need to explain return values. It covers the tool's core purpose and data source. However, it could mention pagination or rate limits, but the schema already handles limit/skip. Overall, it is sufficient for a simple read-only search tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema has 100% coverage, with all parameters (search, limit, skip) described. The description does not add additional meaning beyond the schema's existing descriptions, so baseline score of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool searches the FDA FAERS database for drug adverse event reports, specifying the type of data (side effects, reactions, patient demographics) and the source (OpenFDA). It uses a specific verb ('Search') and resource, which distinguishes it from sibling tools like health.safety.drug_labels or health.clinical.search.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description does not provide explicit guidance on when to use this tool versus alternatives, such as when to use drug_labels instead or what the limitations are. Usage context is implied by the tool's purpose, but no exclusions or recommendations are given.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.